Skip to main content

Soligenix, Inc.

SNGX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0000812796

No open-market purchases or sales by Soligenix, Inc. insiders were filed in the last 90 days; 17 institutions reported holding it in 13F filings for Q2 2026, worth $369.6K in total; no superinvestor holds it.

Q4 2021 vs. Q3 2021

How the institutions holding Soligenix, Inc. changed between Q3 2021 and Q4 2021.

All holders in Q4 2021All holders in Q3 2021

13F holders of SNGX: Q3 2021 compared with Q4 2021
MeasureQ3 2021Q4 2021Change
Holders3428−6
Shares4.11M3.39M−716.2K (−17.4%)
Value$4.35M$2.24M−$2.12M (−48.6%)

New holders (3)

Institutions that held Soligenix, Inc. at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to SNGX in Q4 2021
InstitutionSharesValue% of portfolio
Renaissance Technologies LLC22,000$15.0K0.00%
Money Concepts Capital Corp17,750$12.0K0.00%
Susquehanna International Group, LLP10,090$7.00K0.00%

Sold out (9)

Institutions that held Soligenix, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.

Institutions that sold out of SNGX in Q4 2021
InstitutionShares, Q3 2021Value, Q3 2021
Two Sigma Securities, LLC58,791$62.0K
Virtu Financial LLC51,947$55.0K
WMS Partners, LLC25,000$27.0K
Dock Street Asset Management Inc22,500$24.0K
HRT Financial LP22,659$24.0K
Two Sigma Advisers, LP12,900$14.0K
Clearstead Advisors, LLC12,500$13.0K
Meridian Wealth Partners, LLC5,000$5.00K
Harbour Investments, Inc.1$0